Last update 08 May 2025

ICX-PRO

Overview

Basic Info

Drug Type
Cell therapy
Synonyms
Cyzact, ICX PRO
+ [1]
Target-
Action-
Mechanism
Tissue replacements
Therapeutic Areas
Nervous System DiseasesCardiovascular DiseasesEndocrinology and Metabolic Disease+ [1]
Active Indication-
Inactive Indication
Diabetic FootDiabetic foot ulcerVaricose Ulcer+ [1]
Originator Organization
Intercytex Ltd.
Active Organization-
Inactive Organization
Intercytex Ltd.
Healthpoint Hospital LLC
License Organization-
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with ICX-PRO
EUCTR2006-000692-15-GB
/ Not yet recruitingPhase 2
A prospective single centre, open label, pilot study to evaluate the safety of ICXP007 plus standard of care, for the treatment of lower extremity chronic, neuropathic diabetic foot ulcers - DFU I
NCT00232973
/ Unknown statusPhase 3
A Prospective, Multi-Centre, Double Blind, Randomized, Placebo Controlled Trial to Evaluate the Safety and Efficacy of ICXP007 in a Phase III Trial With Four-Layer Therapeutic Compression, for the Treatment of Non-Infected Skin Leg Ulcers, Due to Venous-Insufficiency
EUCTR2004-002122-22-GB
/ Not yet recruitingPhase 3
A prospective, multi-centre, double blind, randomized, placebo controlled trial to evaluate the safety and efficacy of ICXP007 in a phase III trial with four-layer therapeutic compression, for treatment of non-infected skin leg ulcers, due to venous insufficiency. - TOPICAL II
100 Clinical Results associated with ICX-PRO
Login to view more data
100 Translational Medicine associated with ICX-PRO
Login to view more data
100 Patents (Medical) associated with ICX-PRO
Login to view more data
100 Deals associated with ICX-PRO
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetic foot ulcerPhase 3
United Kingdom
Intercytex Ltd.
03 May 2006
Venous InsufficiencyPhase 3
United Kingdom
Intercytex Ltd.
01 Jul 2005
Venous InsufficiencyPhase 3
Canada
Intercytex Ltd.
01 Jul 2005
Venous InsufficiencyPhase 3
United States
Intercytex Ltd.
01 Jul 2005
Diabetic FootPhase 3-
Healthpoint Hospital LLC
-
Varicose UlcerPhase 3-
Healthpoint Hospital LLC
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free